1-R01-EB035485-01 |
Nanostructured degradable bone cement for delivering novel antibiotics |
Shiladitya Sengupta |
Brigham And Women'S Hospital |
1-R15-EB031388-01 |
Nucleic Acid Nanoparticle-based Monoclonal Antibody Mimics |
Emil Khisamutdinov |
Ball State University |
1-R21-EB034465-01 |
Designing a targeted 'super adjuvant' nanoparticle platform for vaccination |
Prabhani Atukorale |
University of Massachusetts Amherst |
1-R21-EB034942-01 |
Optimization of Tannic Acid Lipid Nanoparticles for a Therapeutic mRNA Vaccine Against Melanoma |
Owen Fenton |
Univ of North Carolina Chapel Hill |
1-R56-EB031848-01A1 |
WIRELESS MAGNETO-MECHANICAL CONTROL OF NEURAL ACTIVITY MEDIATED BY MAGNETIC NANODISCS |
Gabriela Romero Uribe |
University of Texas San Antonio |
4-R00-EB028838-03 |
Anti-biofilm laser-mediated photothermal ablation via complex noble metal nanostructures |
Maryam Hajfathalian |
New Jersey Institute of Technology |
5-P41-EB028239-05 |
The Johns Hopkins Translational ImmunoEngineering (JH-TIE) BTRC |
Jonathan Schneck |
Johns Hopkins University |
5-R01-EB022641-08 |
Targeting of Bio-orthogonal Chemotherapeutic Nanozymes to Tumor-Associated Macrophages |
Vincent Rotello |
University of Massachusetts Amherst |
5-R01-EB026893-05 |
Controllable In Vivo Genome Editing for Immune-Checkpoint Blockade in Solid Tumors |
Sheng Tong |
University of Kentucky |
5-R01-EB027078-04 |
Active Drug Loading to Nanovesicles for Targeted Drug Delivery |
Zhenjia Wang |
Washington State University |